These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 32929369)

  • 1. Identification of second primary tumors from lung metastases in patients with esophageal squamous cell carcinoma using whole-exome sequencing.
    Xue L; Li W; Fan X; Zhao Z; Zhou W; Feng Z; Liu L; Lin H; Li L; Xue X; Huang X; Huang P; Guo J; Du P; Lu N; Li L; Zhan Q; Song Y
    Theranostics; 2020; 10(23):10606-10618. PubMed ID: 32929369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA LPAR3 sponges microRNA-198 to facilitate esophageal cancer migration, invasion, and metastasis.
    Shi Y; Fang N; Li Y; Guo Z; Jiang W; He Y; Ma Z; Chen Y
    Cancer Sci; 2020 Aug; 111(8):2824-2836. PubMed ID: 32495982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiregion sequencing and subclonal analysis reveal intratumoral heterogeneity in esophageal squamous cell carcinoma.
    Gao D; Zhang Z; Yang Q; Li B
    J Cancer Res Ther; 2021 Jul; 17(3):756-763. PubMed ID: 34269310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characteristics of multifocal esophageal squamous cell carcinomas to discriminate multicentric origin from intramural metastasis.
    Li W; Cheng N; Zhao Z; Zheng B; Yang Z; Xu Y; Shao Y; Song Y; Lu N; Xue L
    J Pathol; 2022 Dec; 258(4):395-407. PubMed ID: 36098222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Esophagectomy via upper partial sternotomy for esophageal cancer after previous right pneumonectomy: A case report.
    Okamura A; Watanabe M; Hayami M; Mine S
    J Thorac Cardiovasc Surg; 2018 Dec; 156(6):e217-e220. PubMed ID: 30449589
    [No Abstract]   [Full Text] [Related]  

  • 7. Clonal evolution of esophageal squamous cell carcinoma from normal mucosa to primary tumor and metastases.
    Yuan W; Liu Z; Wang Y; Liu M; Pan Y; Lei W; Yang H; Xu R; Zhang L; Cai H; Li J; Ke Y
    Carcinogenesis; 2019 Dec; 40(12):1445-1451. PubMed ID: 31570939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of Lymph Node Metastasis in Patients with the Superficial Spreading Type of Esophageal Squamous Cell Carcinoma.
    Yachida T; Oda I; Abe S; Sekiguchi M; Nonaka S; Suzuki H; Yoshinaga S; Taniguchi H; Sekine S; Masugata H; Masaki T; Daiko H; Saito Y
    Digestion; 2020; 101(3):239-244. PubMed ID: 30909271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Associated factors of postoperative relapse and metastasis in pT1bN0M0-pT4aN0M0 thoracic esophageal squamous cell carcinoma].
    Pan W; Xiang Y; Gu Z; Ji C; Mao T; Fang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1045-1049. PubMed ID: 28900998
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paired whole exome and transcriptome analyses for the Immunogenomic changes during concurrent chemoradiotherapy in esophageal squamous cell carcinoma.
    Park S; Joung JG; Min YW; Nam JY; Ryu D; Oh D; Park WY; Lee SH; Choi Y; Ahn JS; Ahn MJ; Park K; Sun JM
    J Immunother Cancer; 2019 May; 7(1):128. PubMed ID: 31097034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing second primary tumors from lung metastases in patients with head and neck squamous cell carcinoma.
    Leong PP; Rezai B; Koch WM; Reed A; Eisele D; Lee DJ; Sidransky D; Jen J; Westra WH
    J Natl Cancer Inst; 1998 Jul; 90(13):972-7. PubMed ID: 9665144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristic of esophageal cancer without lugol-voiding lesions in the background esophagus.
    Kuwabara H; Chiba H; Tachikawa J; Okada N; Ashikari K; Arimoto J; Nakaoka M; Sakai E; Goto T; Ohata K
    Dig Endosc; 2020 May; 32(4):621-627. PubMed ID: 31965622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implication of clinical target delineation for T1b/T2 thoracic esophageal squamous cell carcinoma based on the pattern of lymph node metastases.
    Guan H; Yu Y; Ge H; Zhu S; Huang W; Li B
    Future Oncol; 2019 Oct; 15(29):3345-3355. PubMed ID: 31578872
    [No Abstract]   [Full Text] [Related]  

  • 14. Multi-omics profiling of primary small cell carcinoma of the esophagus reveals RB1 disruption and additional molecular subtypes.
    Li R; Yang Z; Shao F; Cheng H; Wen Y; Sun S; Guo W; Li Z; Zhang F; Xue L; Bi N; Wang J; Sun Y; Li Y; Tan F; Xue Q; Gao S; Shi S; Gao Y; He J
    Nat Commun; 2021 Jun; 12(1):3785. PubMed ID: 34145257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of lung tumors in patients with esophageal squamous cell carcinoma and vice versa: a systematic review and meta-analysis.
    van Tilburg L; van de Ven SEM; Spaander MCW; van Kleef LA; Cornelissen R; Bruno MJ; Koch AD
    J Cancer Res Clin Oncol; 2023 May; 149(5):1811-1823. PubMed ID: 35737094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502-A1.
    Oshima K; Kato K; Ito Y; Daiko H; Nozaki I; Nakagawa S; Shibuya Y; Kojima T; Toh Y; Okada M; Hironaka S; Akiyama Y; Komatsu Y; Maejima K; Nakagawa H; Onuki R; Nagai M; Kato M; Kanato K; Kuchiba A; Nakamura K; Kitagawa Y
    Cancer Sci; 2022 Mar; 113(3):1018-1027. PubMed ID: 34962019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of active operation during intensive followup for second primary malignancy after esophagectomy for thoracic squamous cell esophageal carcinoma.
    Motoyama S; Saito R; Kitamura M; Ogawa J
    J Am Coll Surg; 2003 Dec; 197(6):914-20. PubMed ID: 14644278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-region sequencing reveals genetic correlation between esophageal squamous cell carcinoma and matched cell-free DNA.
    Yuan Z; Wang X; Geng X; Li Y; Tan F; Xue Q; Gao S; He J
    Cancer Genet; 2021 Nov; 258-259():93-100. PubMed ID: 34688997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of multiple Lugol-voiding lesions with synchronous and metachronous esophageal squamous cell carcinoma in patients with head and neck cancer.
    Muto M; Hironaka S; Nakane M; Boku N; Ohtsu A; Yoshida S
    Gastrointest Endosc; 2002 Oct; 56(4):517-21. PubMed ID: 12297767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-region sequencing unveils novel actionable targets and spatial heterogeneity in esophageal squamous cell carcinoma.
    Yan T; Cui H; Zhou Y; Yang B; Kong P; Zhang Y; Liu Y; Wang B; Cheng Y; Li J; Guo S; Xu E; Liu H; Cheng C; Zhang L; Chen L; Zhuang X; Qian Y; Yang J; Ma Y; Li H; Wang F; Liu J; Liu X; Su D; Wang Y; Sun R; Guo S; Li Y; Cheng X; Liu Z; Zhan Q; Cui Y
    Nat Commun; 2019 Apr; 10(1):1670. PubMed ID: 30975989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.